Balaxi Pharmaceuticals Ltd. | Small-cap | Healthcare
₹50.05
0.14%
| Balaxi Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 2.9B
Gross Profit 1.3B 43.36%
Operating Income 353.2M 12.07%
Net Income 250.7M 8.57%

Balance Sheet Metrics

Total Assets 3.1B
Total Liabilities 786.1M
Shareholders Equity 2.3B
Debt to Equity 0.34

Cash Flow Metrics

Operating Cash Flow -196.2M
Free Cash Flow -567.7M

Revenue & Profitability Trend

Balaxi Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 2.9B 2.4B 3.4B 2.8B 2.3B
Cost of Goods Sold 1.7B 1.3B 2.0B 2.0B 1.7B
Gross Profit 1.3B 1.1B 1.3B 837.9M 591.9M
Operating Expenses 549.1M 286.6M 368.5M 165.3M 63.1M
Operating Income 353.2M 457.9M 556.6M 503.1M 424.2M
Pre-tax Income 286.7M 20.2M 569.2M 545.2M 443.3M
Income Tax 36.0M 44.0M 109.6M 68.6M 61.9M
Net Income 250.7M -23.9M 459.6M 476.6M 381.4M
EPS (Diluted) - -₹0.46 ₹9.08 ₹9.53 ₹7.63

Income Statement Trend

Balaxi Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.4B 2.1B 1.9B 1.4B 937.7M
Non-Current Assets 675.8M 481.7M 461.6M 354.7M 59.1M
Total Assets 3.1B 2.6B 2.4B 1.8B 996.8M
Liabilities
Current Liabilities 545.3M 542.0M 531.3M 632.7M 346.9M
Non-Current Liabilities 240.7M 27.8M 36.6M 389.0K 67.0K
Total Liabilities 786.1M 569.8M 567.9M 633.1M 347.0M
Equity
Total Shareholders Equity 2.3B 2.0B 1.8B 1.1B 649.8M

Balance Sheet Composition

Balaxi Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 286.7M 20.2M 569.2M 545.2M 443.3M
Operating Cash Flow -196.2M 151.8M 320.9M 135.5M -169.9M
Investing Activities
Capital Expenditures -211.2M -1.7M -108.0M -47.5M -12.8M
Investing Cash Flow -211.2M -1.7M -108.5M -13.8M -46.9M
Financing Activities
Dividends Paid - - -5.0M - -
Financing Cash Flow 367.5M 318.7M 259.6M -212.0K 36.6M
Free Cash Flow -567.7M 33.0M -89.0M 68.0M -25.5M

Cash Flow Trend

Balaxi Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 10.96
Price to Book 1.19
Price to Sales 1.05

Profitability Ratios

Profit Margin -0.99%
Operating Margin 21.39%
Return on Equity -1.24%
Return on Assets 11.20%

Financial Health

Current Ratio 3.88
Debt to Equity 9.64
Beta 0.59

Per Share Data

EPS (TTM) ₹4.54
Book Value per Share ₹41.85
Revenue per Share ₹46.91

Financial data is updated regularly. All figures are in the company's reporting currency.